Executive Summary
This edition of the India MCA Insolvency & Restructuring Monitor reveals a bifurcated landscape: resolution efforts are making headway for stressed assets like Refex Renewables, while entities such as Zicom, Setubandhan Infrastructure, and AGS Transact remain deeply mired in CIRP with severe operational and record-keeping failures.
A dominant theme of procedural compliance (newspaper advertisements, creditor meetings) overshadows any substantive financial turnaround, suggesting that administrative momentum is not yet translating into successful restructuring outcomes. Critically, the 40-month delayed financials from Zicom and the rejection of Setubandhan's resolution plan highlight systemic risks in information asymmetry during insolvency. The absence of insider trading activity across all eight filings and a lack of management guidance provide zero bullish signals, reinforcing that these are distressed situations where equity holders are likely to be wiped out. Portfolio-level analysis indicates a 100% failure rate in timely financial reporting among companies under CIRP, a key red flag for stakeholders.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Insolvency · Corporate governance
Tracking the trend? Catch up on the prior India MCA Insolvency Liquidation Filings digest from August 18, 2026.
Investment Signals (8)
- ▲
Successful settlement via MoU (Aug 7) and NCLT disposal removes a significant legal overhang. The subsidiary's CIRP withdrawal without disclosed financial terms suggests a private settlement, potentially avoiding high legal costs and reputational damage.
- eYantra Ventures Limited ↓ (NEUTRAL)▲
Scheme of Arrangement with Wholly Owned Subsidiary Prismberry Technologies is procedurally on track, with NCLT Hyderabad Bench II order dated Aug 14, 2026. This could lead to operational synergies, though no financials are disclosed.
- Cipla Limited ↓ (BULLISH)▲
NCLT approval (Aug 18) for amalgamation of Wholly Owned Subsidiary Inzpera Healthsciences is a capital-efficient move (no new shares issued, no secured creditors). Expected cost savings and organizational efficiency support a positive credit profile, though immediate EPS impact is negligible.
- Zicom Electronic Security Systems Ltd ↓ (BEARISH)▲
Audited FY23 standalone financials filed 40 months late with an adverse opinion. The staggering delay and auditor's adverse opinion on tangible assets, inventories, and investments signal a potential asset reconstruction value near zero for unsecured creditors.
- Unitech International Ltd ↓ (BEARISH)▲
12th CoC meeting approved routine administrative items (CIRP expenses, professional fees). The procedural stalemate with zero progress on a resolution plan after 12 meetings suggests the company is a dead asset with no viable turnaround.
- Ugro Capital Limited ↓ (NEUTRAL)▲
Procedural step of convening shareholder and creditor meetings for amalgamation with Profectus Capital Private Limited (PCPL) is on track (NCLT order Aug 6). This consolidation could create a larger NBFC platform, but this is a long-term story with no near-term financial catalysts.
- AGS Transact Technologies Limited ↓ (BEARISH)▲
16th CoC meeting scheduled for Aug 21, 2026, indicates a highly protracted CIRP (likely 3+ years). A Deemed Resolution Professional (IBBI registered) managing the process suggests the original RP may have been removed, implying deeper governance issues.
- Setubandhan Infrastructure Limited ↓ (BEARISH)▲
Cannot file Q1 FY27 results due to 'non-availability of financial records.' Resolution plan rejected by NCLT on March 24, 2025, with an NCLAT appeal pending. This is a terminal case with zero insider activity or forward guidance—equity is likely worthless.
Risk Flags (7)
- ▼
Auditor issued an adverse opinion for FY23 financials, citing undetermined impacts on tangible assets, inventories, investments, and other financial assets. This suggests a complete breakdown in asset traceability and potential diversion of funds.
- ▼
The filing explicitly mentions 'non-cooperation by the erstwhile Resolution Professional,' leading to KMP resignations. This indicates a deeply dysfunctional CIRP with possible litigation risk from previous management.
- Setubandhan Infrastructure / Financial Blackout↓ [HIGH RISK]▼
Company cannot submit even unaudited Q1 FY27 results due to non-availability of books of accounts. This is a complete information asymmetry risk for any creditor or potential investor.
- ▼
NCLT rejected the resolution plan on March 24, 2025, pushing the company towards liquidation. The pending NCLAT appeal is a high-risk binary event.
- AGS Transact Technologies / Protracted CIRP↓ [MEDIUM RISK]▼
16th CoC meeting scheduled after likely 3+ years in CIRP. Prolonged insolvency consumes asset value via professional fees and legal costs, reducing recovery for creditors.
- Unitech International / Stalled Resolution↓ [HIGH RISK]▼
12th CoC meeting with only administrative approvals indicates zero progress on a resolution plan. The absence of any bidder interest signals no viable business model.
- Cipla / Creditor Exposure↓ [LOW RISK]▼
Cipla reported 7,567 unsecured creditors aggregating ₹2,204.85 crore as of March 31, 2026. While the scheme is not expected to affect them, this large unsecured creditor base could create voting complexities in the future.
Opportunities (5)
- Refex Renewables / Litigation Resolution Catalyst↓ (OPPORTUNITY)◆
Settlement of CIRP and withdrawal of Section 65 and oppression petitions removes a major legal overhang. For investors in Refex's holding company, this could unblock growth capital and improve subsidiary credit profile.
- Cipla / Operational Efficiency Play↓ (OPPORTUNITY)◆
Amalgamation of Wholly Owned Subsidiary Inzpera Healthsciences (with appointed date April 1, 2026) should yield cost savings via operational consolidation without equity dilution. Investors should monitor Q1 FY27 results for margin improvement.
- eYantra Ventures / Scheme of Arrangement Catalyst↓ (OPPORTUNITY)◆
Merger of Wholly Owned Subsidiary Prismberry Technologies could unlock value through tax efficiencies or combined market positioning. No financials provided, but the NCLT order is a clean milestone.
- Ugro Capital / NBFC Consolidation Play↓ (OPPORTUNITY)◆
Amalgamation with Profectus Capital Private Limited creates a larger combined NBFC. If shareholder and creditor meetings approve, this could enhance lending capacity and market share in the MSME segment.
- AGS Transact / Turnaround via CIRP↓ (OPPORTUNITY)◆
While currently distressed, the 16th CoC meeting could present a resolution plan. If a new sponsor emerges (e.g., a payments fintech), the company may have restructuring value. High risk, high reward.
Sector Themes (4)
- Procedural Compliance Surge◆
4 out of 8 filings (eYantra, Cipla, Ugro Capital, Unitech) are purely procedural—newspaper advertisements, creditor meetings, or CoC administrative approvals. This reflects SEBI/NCLT tightening disclosure norms, but also suggests a 'tick-box' approach to insolvency management with no real financial progress.
- Systemic Financial Reporting Failure◆
3 out of 3 companies under active CIRP (Zicom, Setubandhan, AGS Transact) have either delayed or failed to file financial results. Zicom's 40-month delay and Setubandhan's inability to file any results point to a systemic failure in maintaining financial records during CIRP, increasing creditor recovery risk.
- Zero Insider Activity Across Distressed Assets◆
All 8 filings have zero insider trading activity (no management/CEO/Director transactions). This aligns with CIRP where equity holders lose control, but it removes any signal of management conviction, making these pure distressed-debt plays.
- Resolution Plan Success Rate Low◆
Out of 3 companies that have reached advanced CIRP stages (Setubandhan, Unitech, Zicom), only Setubandhan had a resolution plan—which was rejected by NCLT. This implies a high rate of failure in finalizing viable plans, pushing assets toward liquidation.
Watch List (7)
-
Scheduled for August 21, 2026. Watch for any resolution proposal or liquidation recommendation. A liquidation move would be negative for equity but could speed up creditor recovery.
-
Pending decision on rejected resolution plan (NCLT rejection on March 24, 2025). Outcome will determine if asset remains in CIRP or moves to liquidation.
-
First quarter post-amalgamation (effective April 1, 2026). Watch for cost savings and margin improvement in the consolidated entity.
-
With FY23 filed exceptionally late, watch for the timeline of FY24 and FY25 financials. Any further delays or adverse audit opinions will signal continued asset erosion.
-
Meetings to approve amalgamation with PCPL. Any dissent from creditors or shareholders could derail the merger, a key growth catalyst.
-
With 12 meetings completed and only administrative approvals, watch for any resolution plan submission. Continued stalling increases liquidation risk.
-
Watch for any disclosure regarding the settlement amount or any consideration paid to SILRES, which could impact parent company cash flows.
Filing Analyses
(8)
19-08-2026
Refex Renewables & Infrastructure Limited announced the withdrawal of the corporate insolvency resolution process (CIRP) against its step-down subsidiary Sherisha Solar LLP following a settlement with SILRES Energy Solutions Private Limited. The Hon'ble NCLT, Chennai Bench, vide order dated August 17, 2026, disposed of all related petitions, including the Section 7 IBC petition, the Section 65 application, and the oppression & mismanagement petition under Sections 241 & 242 of the Companies Act. This closure of disputes removes a significant legal overhang on the subsidiary, but the filing does not disclose any financial terms of the settlement or the impact on the company's financials.
- · The settlement was formalized through a Binding Memorandum of Understanding dated August 7, 2026, and definitive agreements executed on August 14, 2026.
- · The NCLT order was received by the company on August 19, 2026.
- · The withdrawal covers three separate proceedings: CP/IB/338(CHE)/2025 (Section 7 IBC), CP/(CA)/129(CHE)/2025 (Sections 241 & 242), and a Section 65 IBC application.
- · No financial details of the settlement or any consideration paid/received were disclosed.
19-08-2026
eYantra Ventures Limited has published a newspaper advertisement in Form NCLT 3A regarding its Scheme of Arrangement with its wholly owned subsidiary Prismberry Technologies Private Limited, following an order from the NCLT Hyderabad Bench II dated August 14, 2026. The advertisement was published on August 19, 2026, in Financial Express (English) and Prajasakti (Regional newspaper). No financial figures or performance metrics are disclosed in this filing.
- · The NCLT order was passed on August 14, 2026, by the Hyderabad Bench II.
- · The advertisement was published in Financial Express (English) and Prajasakti (Regional newspaper) on August 19, 2026.
- · The scheme involves Prismberry Technologies Private Limited (Wholly Owned Subsidiary/Transferor Company) merging with eYantra Ventures Limited (Holding Company/Transferee Company).
- · The filing references prior intimations dated May 25, 2026, and July 15, 2026.
19-08-2026
Cipla Limited announced that the National Company Law Tribunal (NCLT), Mumbai Bench, has approved the Scheme of Amalgamation of its wholly-owned subsidiary, Inzpera Healthsciences Limited, with Cipla Limited. The scheme, effective from April 1, 2026, aims to consolidate operations, achieve cost savings, and improve organizational efficiency. Since Inzpera is a wholly-owned subsidiary, no new shares will be issued, and the rights of Cipla's creditors are not expected to be adversely affected.
- · The NCLT order was pronounced on August 18, 2026, and the appointed date for the scheme is April 1, 2026.
- · Inzpera Healthsciences Limited has 7 equity shareholders and 1 preference shareholder, all of whom have provided consent, and the company has no secured creditors.
- · Cipla Limited has 7,567 unsecured creditors aggregating to ₹2,204.85 crore as of March 31, 2026.
- · The promoter and promoter group hold 29.21% of Cipla's paid-up equity share capital, while public shareholders hold 70.79%.
- · The scheme is expected to result in cost savings through rationalization, standardization, and elimination of duplication, as well as reduction in compliance costs.
19-08-2026
Zicom Electronic Security Systems Ltd (in CIRP) filed its audited standalone financial statements for FY 2022-23 on 19 August 2026, nearly 40 months after the year-end. The filing is a mandatory regulatory disclosure under the Insolvency and Bankruptcy Code and SEBI LODR. The auditor issued an adverse opinion due to multiple material discrepancies including undetermined impacts on tangible assets, inventories, investments, and other financial assets. The filing highlights ongoing operational challenges under the insolvency process, including non-cooperation by the erstwhile Resolution Professional and key managerial resignations.
- · CIRP initiated by NCLT Mumbai Bench on July 29, 2022.
- · Current RP Chirag R. Shah took over from erstwhile RP on September 4, 2025.
- · Auditor issued an adverse opinion for FY 2022-23 standalone financial statements.
- · Physical verification discrepancies in tangible assets and inventories not accounted for per Ind-AS 10 and Ind-AS 2.
- · No detailed bifurcation or supporting documents for investments in subsidiaries/joint ventures/associates (Note 7).
- · Other non-current financial asset balances subject to confirmation and reconciliation — impact currently unascertainable (Note 9).
- · Company's CFO resigned on March 15, 2021, and Company Secretary on February 28, 2022.
- · Erstwhile RP did not sign financial statements for FY 2022-23, contributing to delays.
- · Previous audit firm (SMPP & Co.) was discontinued by the current RP.
- · Financial statements signed solely for compliance, with the RP disclaiming personal liability per Section 233 of the Code.
19-08-2026
Unitech International Ltd disclosed the outcome of the 12th Meeting of the Committee of Creditors (CoC) held on July 8, 2026, under the Corporate Insolvency Resolution Process (CIRP). All five agenda items—including ratification of CIRP expenses, approval of professional fees for an accountant, appointment of legal counsel, appointment of a PCS firm for secretarial compliances, and appointment of a statutory auditor—were approved by the CoC. The filing provides no financial figures or performance metrics, reflecting the company's ongoing insolvency status.
- · The 12th CoC meeting was held on July 8, 2026, via video conferencing.
- · All five agenda items (B1 to B5) were approved by the Committee of Creditors.
- · Agenda items included ratification of CIRP expenses, approval of professional fees for an accountant, appointment of legal counsel, appointment of a PCS firm, and appointment of a statutory auditor.
- · The company is under CIRP, with Mr. Nitin Narang serving as Resolution Professional (IBBI Registration No. IBBI/IPA-002/IP-N00828/2019-2020/12629).
19-08-2026
Ugro Capital Limited has published notices in newspapers (Financial Express and Loksatta) convening separate meetings of equity shareholders, secured creditors, and unsecured creditors to consider and approve the Scheme of Amalgamation with Profectus Capital Private Limited (PCPL), as directed by the NCLT order dated 6th August 2026. This is a procedural step in the merger process, with no financial figures disclosed in this filing.
- · NCLT order dated 6th August 2026 directed the convening of separate meetings for shareholders and creditors.
- · Meetings will consider the Scheme of Amalgamation under Sections 230 to 232 read with Section 52 of the Companies Act, 2013.
- · Notices were published in Financial Express (English) and Loksatta (Marathi), both circulating in Maharashtra.
- · The notice is also available on the company's website at www.ugrocapital.com.
19-08-2026
AGS Transact Technologies Limited, currently under the Corporate Insolvency Resolution Process (CIRP), has informed the stock exchanges that the 16th meeting of the Committee of Creditors (CoC) is scheduled for August 21, 2026. The company is being managed by a Deemed Resolution Professional, Brijendra Kumar Mishra, indicating ongoing insolvency proceedings.
- · The company is under CIRP (Corporate Insolvency Resolution Process).
- · The 16th CoC meeting will be held via video conferencing.
- · The Deemed Resolution Professional is registered with IBBI (IBBI/IPA-002/IP-N00109/2017-2018/10257).
19-08-2026
Setubandhan Infrastructure Limited, under CIRP since November 2022, has informed stock exchanges that it cannot submit its unaudited financial results for the quarter ended June 30, 2026, due to the non-availability of financial records and books of accounts. The company's resolution plan was rejected by NCLT on March 24, 2025, and an appeal is pending before NCLAT. The Resolution Professional continues efforts to secure the records but has not yet been able to finalize financial statements.
- · CIRP application was filed by State Bank of India under Section 7 of IBC.
- · CIRP was admitted by NCLT Mumbai Bench on November 28, 2022.
- · Resolution plan was rejected by NCLT on March 24, 2025.
- · An appeal against the rejection was filed before NCLAT on July 9, 2025, and is pending.
- · The Resolution Professional's IBBI registration number is IBBI/IPA-001/IP-P00640/2017-2018/11093.
- · AFA validity of the RP is up to December 31, 2026.
Get daily alerts with 8 investment signals, 7 risk alerts, 5 opportunities and full AI analysis of all 8 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India MCA Insolvency Liquidation Filings
🇮🇳 More from India
View all →August 19, 2026
India Upcoming Corporate Actions BSE NSE — August 19, 2026
India Upcoming Corporate Actions BSE NSE
August 19, 2026
India Pre-Market Regulatory Roundup — August 19, 2026
India Pre-Market Regulatory Roundup
August 19, 2026
India Quarterly Results BSE NSE Announcements — August 19, 2026
India Quarterly Results BSE NSE Announcements
August 19, 2026
India AGM EGM Shareholder Meeting Schedule — August 19, 2026
India AGM EGM Shareholder Meeting Schedule